Interferon-α associated with agranulocytosis during medication with clozapine;Interferon-α-assoziierte agranulozytose während clozapin-behandlung: Kasuistik und wissensstand

Nervenarzt

Volumn 72, Issue 11, 2001, Pages 872-875

  Schafer M ^a   Schmidt, F ^a   Grunze, H ^a   Laakmann, G ^a   Loeschke, K ^b  

^a UNIVERSITY OF MUNICH   (Germany)

^b LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

Author keywords

Agranulocytosis; Antipsychotics; Hepatitis C; Interferon ; Psychiatric patients

Indexed keywords

ALPHA INTERFERON; CLOZAPINE;

ADULT; AGRANULOCYTOSIS; ARTICLE; BLOOD TOXICITY; BONE MARROW EXAMINATION; CASE REPORT; CHRONIC HEPATITIS; DISEASE COURSE; DISEASE SEVERITY; DOSE RESPONSE; DRUG WITHDRAWAL; GENOTYPE; GRANULOCYTOPENIA; HEPATITIS C; HUMAN; LEUKOCYTE COUNT; MALE; PARANOID PSYCHOSIS; PSYCHOPHARMACOTHERAPY; TREATMENT OUTCOME;

ADULT; AGRANULOCYTOSIS; CANNABINOIDS; CLOZAPINE; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION SCHEDULE; DRUG INTERACTIONS; DRUG THERAPY, COMBINATION; FOLLOW-UP STUDIES; HEPATITIS C; HEROIN DEPENDENCE; HUMANS; INTERFERON ALFA-2A; LYSERGIC ACID DIETHYLAMIDE; MALE; PSYCHOSES, SUBSTANCE-INDUCED; SUBSTANCE ABUSE, INTRAVENOUS;

EID: 0035182921     PISSN: 00282804     EISSN: None     Source Type: Journal    
DOI: 10.1007/s001150170022     Document Type: Article

References (28)

1. Neuropsychiatric manifestation of human leukocyte interferon therapy in patients with cancer
2. Treatment of schizophrenic disorder, paranoid type, with intramuscular recombinant alpha-2b interferon
3. Granulozytopenia after combined therapy with interferon and angiotensin-converting enzyme inhibitors: Evidence for a synergistic hematologic toxicity
4. Schizophrenic psychosis: A contraindication for treatment of hepatitis C with interferon alpha?
5. Side effects of alpha interferon in chronic hepatitis C
6. Investigators of the Italian Association for the study of liver: A survey of adverse events in 11241 patients with chronic viral hepatitis treated with alfa interferon
7. G-CSF and the management of clozapine-induced agranulocytosis
8. Interferon-alpha-2a
9. Case report: Agranulozytosis induced by interferon-alpha therapy for chronic hepatitis C
10. Bone marrow hypoplasia and fibrosis following interferon treatment
11. Suicide associated with alpha-interferon therapy for chronic viral hepatitis
12. Die wichtigsten nebenwirkungen unter clozapin (Leponex) und ihre behandlung
13. HLA-B38, DR4, DQw3 and clozapine-induced agranulocytosis in Jewish patients with schizophrenia
14. Impact of psychiatric disorders on treatment of patients with hepatitis C
15. Interferons as mediators of psychiatric morbidity
16. Neurotoxicity of interferon-alpha
17. Blutbildverän-derungen und andere schwerwiegende nebenwirkungen unter clozapintherapie
18. Treatment with interferon-alpha in patients with chronic hepatitis and mood or anxiety disorders
19. Meta-analysis of interferon randomised trials in the treatment of viral hepatitis C: Effects of dose and duration
20. Interferon-alpha: Zum problem der persistierenden neurotoxizität
21. Psychiatric complications of long-term interferon alpha therapy
22. Side effects of alpha interferon
23. Psychiatrische nebenwirkungen während adjuvanter therapien mit interferon-alpha bei patienten mit malignen melanomen
24. Therapie der chronischen hepatitis C bei ehemals intravenbs drogenabhängigen und patienten in metha-donsubstitutionsprogrammen-internistische, suchtmedizinische und psychiatrische aspekte
25. Adding low-dose antidepressants to interferon-alpha treatment for chronic hepatitis C improved psychiatric tolerability in a patient with schizoaffective psychosis
26. Interferon-alpha can be successfully used in patients with hepatitis C virus-positive chronic hepatitis who have psychiatric illness
27. Interaktionen von clozapin mit anderen psychopharmaka
28. Behandlung der chronischen virushepatitis